default author photo

Felix Ehret

Harvard University

SCHOLARLY PAPERS

2

DOWNLOADS

197

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

The Impact of TERT Promoter Mutation on Meningioma Outcome is Context-Dependent: Implications for Clinical Grading and Risk Stratification

Number of pages: 27 Posted: 31 Jan 2025
New York University (NYU) - NYU Langone Health, Harvard University, New York University (NYU) - NYU Langone Health, Harvard University, Yale University, Yale University, University of California, San Francisco (UCSF), Baylor University, New York University (NYU) - NYU Langone Health, Northwestern University - Feinberg School of Medicine, Northwestern University - Feinberg School of Medicine, Northwestern University - Feinberg School of Medicine, Harvard University, University of Toronto, University of Toronto, University of Pennsylvania, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Heidelberg University - University Hospital Heidelberg, University of Hamburg - University Cancer Center Hamburg, Harvard University, University of Hamburg - Institute of Neuropathology, Harvard Medical School - Department of Pathology, Heidelberg University - University Hospital Heidelberg, Memorial Sloan Kettering Cancer Center, University of Pennsylvania, Mount Sinai Health System - Icahn School of Medicine, University of Texas at Dallas - Southwestern Medical Center, University of Toronto - Unity Health Toronto, University of Toronto, Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin, Northwestern University - Feinberg School of Medicine, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health, Baylor University, University of California, San Francisco (UCSF), Yale University, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health and Harvard University
Downloads 176 (428,796)

Abstract:

Loading...

meningioma, tert promoter mutation, CDKN2A/B deletion, WHO grading

2.

Radiotherapy and Immunotherapy Combinations for Unresectable Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review of Published and Ongoing Clinical Trials from the Y-ECI ROSC EORTC Group

Number of pages: 43 Posted: 14 May 2026
Hospital Quirónsalud, Cantonal Hospital Aarau, Babeș-Bolyai University, Harvard University, Universidad de Alcalá - Hospital Universitario Ramón y Cajal, University of Groningen - University Medical Center Groningen, Utrecht University - University Medical Center (Utrecht), Masaryk Memorial Cancer Institute, Gustave Roussy, The Christie NHS Foundation Trust and University Hospital Zurich
Downloads 21 (1,448,301)

Abstract:

Loading...

Radiotherapy, Immunotherapy, Non-Small Cell Lung Cancer, Immune Checkpoint Inhibitors, Radiation Therapy